Objective The aim of this study was to investigate the relationship between the high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6) and homocysteine (Hcy) levels and cardiometabolic risk factors in subjects with and without metabolic syndrome (MetS) in a sample of the Tehranian population. Methods In this cross-sectional study, 365 individuals aged ! 19 years were randomly selected from among participants of the Tehran Lipid and Glucose Study (TLGS). The serum levels of IL-6, hsCRP and Hcy were determined using the Enzyme Linked Immunosorbent Assay (ELISA) method. Results Of the 365 subjects, aged a mean of 46.1±16.1 years, MetS was present in 160 (43.8%) individuals. The levels of hsCRP, Hcy and IL-6 were higher in the subjects with MetS. A gradual and significant increase in the levels of hsCRP was found in association with increasing numbers of MetS components after adjusting for sex and age. A strong linear augmentation in the hsCRP levels was observed as the numbers of MetS components increased. Additionally, an increase of 0.40 was observed in the hsCRP levels in association with increases in each component of MetS adjusted for age and sex. The best predictors for the levels of hsCRP, IL-6 and Hcy in the subjects with MetS were hip, waist to height ratio (WHtR) and height, respectively. Conclusion Hip and WHtR are significant predictors of elevated levels of hsCRP and IL-6 associated with MetS, respectively.
Introduction
Metabolic syndrome (MetS) is a common clinical disorder characterized by the clustering of cardiovascular risk factors such as central obesity, impaired glucose tolerance, hypertension and dyslipidemia (1) . MetS is a risk factor for type 2 diabetes, cardiovascular diseases (CVD) and cancer (2) and is becoming increasingly important due to the worldwide epidemic of obesity. As suggested by the results of epidemiological studies, MetS is a typical condition of middle-aged and older people (3) .
Atherosclerosis is a basic starting point of MetS and is deeply associated with the disease. Many basic investigators have proven that inflammation plays an important role in the development and progression of atherosclerosis, and many studies have focused on the relationships between factors related to inflammation and the severity of MetS (4) .
Of late, many reports have been published in Western countries regarding the high sensitivity C-reactive protein (hsCRP) levels and their association with cardiometabolic risk factors (5) . However, there are ethnic differences in CRP concentrations and the degree of correlation between the hsCRP levels and cardiovascular risk factors (6) .
Moreover, there are a few reports relating the interleukin-6 (IL-6) levels to non-metabolic risk factors and markers of inflammation, hemostasis and endothelial dysfunction in the general population (7, 8) . The circulating cytokine IL-6 levels play an important role in mediating inflammation and IL-6 is a key cytokine in the acute phase response (9, 10) .
Finally, homocysteine (Hcy) has been recently suggested to be a risk factor as well as a prognostic factor for the development and progression of cardiovascular disease (11, 12) . The Hcy levels have been reported to be elevated in up to 30% of patients diagnosed with atherosclerosis, and Hcy levels only 12% above the upper limit of normal are associated with a 3-fold increase in the risk of acute myocardial infarction (13) .
The levels of hsCRP, Hcy and IL-6 are moving to the forefront as potent predictors of MetS. Since there are no reports regarding the associations between these inflammatory markers and metabolic risk factors in the Tehranian population, we aimed to investigate the relationships between the hsCRP, IL-6 and Hcy levels and cardiometabolic risk factors in subjects with and without MetS in a sample of the Tehranian population.
Materials and Methods

Subject recruitment
This study involved the participation of 365 Tehranian subjects who participated in the Tehran Lipid and Glucose Study (TLGS), a population-based study conducted to determine the prevalence of non-communicable diseases among Tehran's urban population and to develop population-based measures to decrease the prevalence and prevent the rising trend of diabetes mellitus and dyslipidemia. The design of the TLGS included two major components: a cross-sectional prevalence study of cardiovascular disease and associated risk factors and a prospective 20-year follow-up study conducted in several phases at approximately 3.6 year intervals (phase I: 1999-2001, phase II: 2002-2005 and phase III: [2006] [2007] [2008] . A multistage, stratified, clustered random sampling technique was used to select 15,005 people aged 3 years and older from district 13 of Tehran, the capital of Iran. The district is located in the center of Tehran, and the age distribution of its population is representative of the overall population of Tehran (14) . In this cross-sectional study, 365 individuals, including 134 men and 231 women, aged ! 19 years were randomly selected using a random number table during phase III of the TLGS.
Definition of MetS
MetS was defined according to the Joint Interim Statement (JIS) criteria (15) as the presence of three or more of the following features: a triglyceride (TG) level ! 150 mg/dL or the use of medications; a high-density lipoproteincholesterol (HDL-C) level <40 mg/dL in men and <50 mg/ dL in women or the use of medications; systolic blood pressure (SBP) ! 130 mmHg and/or diastolic blood pressure (DBP) ! 85 mmHg or the use of drug treatment; a fasting blood glucose (FBS) level ! 100 mg/dL or the use of drug treatment; and a waist circumference (WC) >89 cm in men and >91 cm in women (16) .
Anthropometric and biochemical characterizations
Anthropometric measurements, including height, weight, waist circumference, hip circumference and wrist circumference, were obtained in all subjects, as previously described (17, 18) . For each subject, the body mass index was calculated by dividing the weight (kg) by the height (m 2 ). The waist to hip ratios (WHR) and the waist to height ratios (WHtR) were also calculated. SBP and DBP were recorded using a standard sphygmomanometer after at least 10 minutes of rest. All assays, including those of the FBS, TG, total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C) and HDL-C levels, were performed on the day of sampling. The FBS levels were measured using the glucose oxidase method (Glucose kit; Pars Azmun, Tehran, Iran). The TG and TC levels of the samples were determined using the enzymatic colorimetric method (TG and TC kit; Pars Azmun, Tehran, Iran). The HDL-C and LDL-C levels of the samples were determined using the precipitation and enzymatic colorimetric method (HDL-C and LDL-C kit; Pars Azmun, Tehran, Iran). The plasma C-reactive protein (hsCRP), Hcy and IL-6 levels were measured using Enzyme Linked Immunosorbent Assay (ELISA) kits (dbc co. Canada, diazyme co. U.S.A and dia clone co. France, respectively). The TG to HDL-C ratios, TC to HDL-C ratios and LDL-C to HDL-C ratios were calculated.
Statistical analysis
The Kolmogorov-Smirnov goodness-of-fit test was used to assess normal distributions of continuous data. All continuous data are expressed as the mean ± standard deviation. Categorical variables are expressed as percentages. Logarithmic transformation was performed to normalize the distributions of DBP, TG, Hcy, hsCRP and IL-6. The means were compared using a two-tailed unpaired sample t-test. Bivariate linear correlations were estimated using Pearson's correlation coefficient. A stepwise linear regression analysis was applied to investigate the associations between hsCRP, Hcy and IL-6 as dependent variables and anthropometric and biochemical variables as independent variables. All statistical analyses were performed using SPSS software (version 15; SPSS, Chicago, IL, USA). All statistical tests were twosided, and differences with probability values <0.05 were considered statistically significant. 
Results
Of the 365 subjects, aged a mean of 46.1±16.1 years, MetS was present in 160 (43.8%) individuals. The clinical characteristics of the populations with and without MetS are shown in Table 1 . The means of all variables were significantly higher in the subjects affected with MetS than in the subjects without MetS, except for the levels of IL-6 and Hcy. In addition, the risk of having a lower level of HDL-C was higher in the group with MetS. The levels of hsCRP, Hcy and IL-6 were higher in the subjects with MetS than in the normal group ( Fig. 1 ).
We divided our study subjects into three subgroups based on the number of MetS components present as follows (as shown in Fig. 2 ): 1) individuals not carrying any of metabolic abnormalities (0); 2) individuals carrying one or two components of MetS (1 or 2); 3) individuals carrying three or more components of MetS (! 3). A gradual and significant increase in the levels of hsCRP was found in association with increasing numbers of MetS components after adjusting for sex and age. A strong linear augmentation in the hsCRP levels was observed as the numbers of MetS components increased from 0 to ! 3, with median hsCRP levels of 6.27, 6.59 and 7.51 (ng/mL) (ptrend =23×10 -5 ) (Fig. 2) . Additionally, an increase of 0.40 in the hsCRP levels (CI 95%: 0.17-0.63; p =69×10 -5 ) was observed in association with increases in each component of MetS in the linear regression analysis after being adjusted for age and sex.
To identify potential confounders prior to inclusion of the variables in a linear regression model, a bivariate Pearson correlation analysis between the levels of hsCRP, Hcy and IL-6 and all cardiometabolic risk factors was performed (Table 2). In the MetS group, the hsCRP levels were found to be highly correlated with BMI, height, hip circumference, WHtR and the levels of TC, LDL-C and IL-6. The variables found to be correlated with the IL-6 levels were age, BMI, waist circumference, WHR, SBP, WHtR and the levels of hsCRP. Moreover, the Hcy levels were found to be highly correlated with sex, height and WHtR. On the other hand, in the group without MetS, the hsCRP levels were found to be highly correlated with age, BMI, weight, waist circumference, hip circumference, WHR, wrist circumference, SBP, WHtR and the levels of cholesterol, LDL-C, DBP, TG, TC/ HDL-C and LDL-C/HDL-C. The variables found to correlate with the IL-6 levels were hip circumference and WHtR, while those found to correlate with the Hcy levels were sex, height, WHR and wrist circumference.
The variables found to be most strongly correlated with the levels of hsCRP, IL-6 and Hcy were selected for a linear stepwise regression analysis ( Table 3 ). The best predictors of the levels of hsCRP, IL-6 and Hcy in the subjects with MetS were hip circumference, WHtR and height, respectively, while WHtR and wrist circumference were the best predictors of the hsCRP and Hcy levels, respectively, in the subjects without MetS. 
Discussion
We investigated the relationships between the hsCRP, IL-6 and Hcy levels and cardiometabolic risk factors in subjects with and without MetS. Our study clearly showed that selected markers of inflammation are substantially increased in subjects with MetS compared with that observed in normal subjects, irrespective of age and sex. Furthermore, in our study, the risk markers increased considerably in association with increasing numbers of MetS components.
Inflammation predisposes individuals to developing atherothrombosis and is associated with features of MetS (19, 20) . Our results detected positive correlations between the inflammation markers hsCRP and IL-6 and WHtR, and negative correlation between Hcy and WHtR among the subjects with MetS.
Previous studies have reported a significant association between the CRP levels and MetS (21) . In our study, we observed a significant increase in the hsCRP, Hcy and IL-6 levels in subjects with MetS. The multiple linear regression analysis showed that hip circumference and WHtR are the main independent variables associated with the levels of hsCRP and IL-6, respectively, in subjects with MetS. These observations are in concordance with the results of previous reports investigating other populations (22, 23) .
WHtR is a more sensitive early warning sign of health risks than BMI. WHtR is significantly associated with all risk factors for obesity and metabolic syndrome and can predict morbidity and mortality in longitudinal studies, often better than BMI (24, 25) . Furthermore, the use of WHtR can often identify people within the moderate range of BMI who have higher metabolic risks, almost certainly because WHtR is more closely associated with central obesity (26) . WHtR can be even more sensitive than WC in different populations, possibly because it encompasses adjustments to different statures (27) (28) (29) (30) (31) and because of the negative correlation between height and certain metabolic risk factors (32) . The association between hip circumference and MetS can be explored by considering the effects of waist circumference. The risks of metabolic syndrome attributable to waist circumference might be underestimated if the effects of hip circumference are not considered. It has been shown that WHtR and hip circumference exhibit independent and opposite effects on metabolic health risks. Whereas WHtR is positively associated with health risks, hip circumference is negatively associated with health risks (33, 34) . This implies a protective effect of a large hip circumference, which could be the result of greater amounts of lean mass in nonabdominal regions. Indeed, lean body mass is negatively associated with all-cause mortality (35) . When this fact is coupled with the knowledge that WHtR is a predictor of MetS (36) , it seems reasonable to suggest that, for a given WHtR value, a higher hip circumference may not indicate an increased health risk. Addressing this issue could have important implications for determining the manner in which WHtR and hip circumference are used to predict metabolic disorders in both research and the clinical settings.
The components of MetS are individually and interdependently strong risk factors for high cardiovascular morbidity and mortality. People with MetS are two times more likely to die from coronary heart disease (37) and three times more likely to have heart attacks and strokes (38) . Intraabdominal adiposity (IAA) is a major contributor to increased cardiometabolic risks. Visceral fat is metabolically active tissue that produces various pro-inflammatory and prothrombotic cytokines. Furthermore, the associations between fatty liver and abdominal visceral adipose tissue (VAT) and cardiometabolic syndrome have been studied in the Jackson Heart Study (39) . Both fatty liver and abdominal visceral adipose tissue are independent correlates of cardiometabolic risks; however, the association is stronger for VAT than for fatty liver.
In a case-controlled study by Yusuf et al. (40) , various cardiometabolic factors associated with the risk of myocardial infarction were identified. That study also demonstrated that WHtR is a more sensitive parameter than BMI and WC for predicting MetS. Recently, one of the first pieces of statistical evidence from a study involving more than 300,000 adults demonstrated the superiority of the waist-to-height ratio as a cardiometabolic risk factor over WC and BMI (41) .
Our study provides further evidence for the association between obesity and the previously mentioned inflammatory factors and demonstrates an association between the levels of hsCRP, Hcy and IL-6 and an increased risk of MetS for the first time in Tehran.
However, our results are subject to several limitations. First, the cross-sectional study design is limited in its ability to eliminate casual relationships between lipid profiles and MetS-associated variables. Second, the sample size of the screened population was small. Third, this study did not include measurements of fat mass and body fat distribution that might potentially affect the CRP, Hcy and IL-6 levels and could better highlight the associations between obesity and inflammatory markers. Fourth, no detailed inquiries were made regarding dietary habits that might potentially affect hsCRP, Hcy and IL-6 production and control the associations between these factors and metabolic parameters.
In conclusion, to the best of our knowledge, this is the first study to determine the associations between inflammatory factors and metabolic risk factors in a Tehranian population. The CRP level is strongly correlated with metabolic risk factors. In addition, WHtR is a significant predictor of elevated levels of hsCRP and IL-6 correlated with MetS. Conducting further studies in larger sample populations is needed to confirm these data. The high prevalence of MetS in this population underlines the need to screen for metabolic risk factors and MetS and to acquire more knowledge regarding the causes and mechanisms underlying the risk factors and the potential for interventions, e.g. diet and physical activity, to reduce the risk factors and thereby the risk of disease.
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